The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...

NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...

Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.